Bessemer Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bessemer Securities’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,136	Closed	-$575K	–	106
2023 Q3	$575K	Sell	1,136 -395	-26%	-$210K	0.8%	33
2023 Q2	$799K	Sell	1,531 -1,775	-54%	-$958K	0.53%	74
2023 Q1	$1.91M	Sell	3,306 -650	-16%	-$366K	0.89%	34
2022 Q4	$2.18M	Sell	3,956 -1,178	-23%	-$624K	0.98%	31
2022 Q3	$2.6M	Sell	5,134 -393	-7%	-$220K	0.94%	22
2022 Q2	$3M	Hold	5,527	–	–	1.05%	17
2022 Q1	$3.27M	Hold	5,527	–	–	0.95%	20
2021 Q4	$3.69M	Buy	5,527 +1,192	+27%	+$744K	1%	21
2021 Q3	$2.48M	Buy	4,335 +1,311	+43%	+$720K	0.84%	24
2021 Q2	$1.53M	Sell	3,024 -1,095	-27%	-$517K	0.6%	44
2021 Q1	$1.88M	Buy	4,119 +244	+6%	+$116K	0.8%	26
2020 Q4	$1.8M	Sell	3,875 -525	-12%	-$246K	0.76%	13
2020 Q3	$1.94M	Buy	4,400 +75	+2%	+$31K	0.9%	10
2020 Q2	$1.57M	Hold	4,325	–	–	0.8%	12
2020 Q1	$1.23M	Buy	4,325 +1,020	+31%	+$322K	0.61%	31
2019 Q4	$1.07M	Hold	3,305	–	–	0.42%	37
2019 Q3	$963K	Hold	3,305	–	–	0.4%	44
2019 Q2	$971K	Hold	3,305	–	–	0.41%	45
2019 Q1	$905K	Sell	3,305 -1,450	-30%	-$361K	0.31%	48
2018 Q4	$1.06M	Buy	+4,755	New	+$1.12M	0.4%	42

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bessemer Securities's TMO Position: Q4 2023 in Review

Bessemer Securities sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 1,136 shares — an estimated $575K sold.

Bessemer Securities first reported a position in TMO in Q4 2018 and held it in 20 quarters. The position peaked at $3.69M in Q4 2021. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Bessemer Securities reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Bessemer Securities sold 1,136 Thermo Fisher Scientific shares in Q4 2023, an estimated $575K.
Bessemer Securities first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 20 quarters.
Bessemer Securities's Thermo Fisher Scientific position peaked at $3.69M in Q4 2021.
2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Bessemer Securities's 13F filing for Q4 2023.